Clear Street Asserts Buy Rating on Annexon, Inc. (ANNX) amid Progress on Pipeline Development
Annexon Inc. (NASDAQ:ANNX) is one of the best multibagger penny stocks to buy right now. On December 1, Clear Street initiated coverage of Annexon Inc.
Annexon Inc. (ANNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 10,050,644 | $50,454,233 | +60% | 3.72% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 9,128,080 | $45,822,962 | +31% | 1.54% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 5,500,000 | $27,610,000 | +267% | 0.04% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 4,000,074 | $20,080,371 | +52% | 0.08% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 3,299,256 | $16,562,265 | +155% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.02 | 4,115 | $20,657.30 | 54,405 | 2025-12-30 | Filing | |
| $4.19 | 33,000 | $138,270.00 | 33,000 | 2025-12-01 | Filing | |
| $4.47 | 4,115 | $18,394.05 | 50,290 | 2025-12-01 | Filing | |
| $4.28 | 422,613 | $1,808,783.64 | 9,728,637 | 2025-11-21 | Filing | |
| $4.48 | 400,000 | $1,792,000.00 | 9,306,024 | 2025-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 5,290 | $26,979.00 | 73,152 | 2026-02-18 | Filing | |
| $5.11 | 7,851 | $40,118.61 | 113,765 | 2026-02-18 | Filing | |
| $5.10 | 5,290 | $26,979.00 | 123,487 | 2026-02-18 | Filing | |
| $5.11 | 7,857 | $40,149.27 | 97,227 | 2026-02-18 | Filing | |
| $5.10 | 6,225 | $31,747.50 | 124,464 | 2026-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,222,470 | $51,316,800 | 0% | |
| 2. | 8,960,434 | $44,981,380 | 0% | |
| 3. | 7,753,387 | $38,922,003 | 0% | |
| 4. | 5,249,069 | $26,350,326 | 2.02% | |
| 5. | 5,157,290 | $25,889,596 | 0.49% |
News See All
14 Best Multibagger Penny Stocks to Buy Right Now
The Russell 2000 Index has hit fresh highs heading into 2026, signaling renewed interest in small companies.
Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement
On November 19, 2025, The Fly reported that Wells Fargo increased its price target on Annexon, Inc. (NASDAQ:ANNX) from $14 to $27, while reiterating an “Overweight” rating.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Nuveen Expands Portfolio With Annexon, Inc. (ANNX) Acquisition
Annexon, Inc. (NASDAQ:ANNX) is among the best fast money stocks to buy now. During the first quarter, Nuveen LLC acquired a new position in Annexon, Inc.
11 Best Fast Money Stocks to Buy Now
In this fast-paced world, most people have become impatient. Everyone is drawn to whatever delivers quick results, whether it be fast fame or fast money.
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
10 Buy-Rated Stocks with Latest Insider Purchases
In this article, we will take a detailed look at the 10 Buy-Rated Stocks with Latest Insider Purchases. For a quick overview of such stocks, read our article 5 Buy-Rated Stocks with Latest Insider...
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
Hedge Fund and Insider Trading News: Bill Ackman, Richard Mashaal, Cheyne Capital Management, Three Arrows Capital, Man Group, Annexon Inc (ANNX), Rocket Companies, Inc. (RKT), and More
Billionaire investor William Ackman, who had raised $4 billion in the biggest-ever special purpose acquisition company (SPAC), told investors he would be returning the sum after failing to find a suitable...
Hedge Fund Resource Center